In endometrial cancer, low ascorbate levels are associated with high hypoxia-inducible factor-1α (HIF-1α) activation, HIF-1α-mediated up-regulation of glucose transporter 1 (GLUT-1) and an aggressive tumour phenotype [17]. This evidence concerns the gene HIF1A and endometrial cancer.